Table 3 Immunohistochemistry for AQP1 and AQP5: number of subjects with maximal scores for extent and intensity
Controls (n = 15) | COPD (n = 15) | p* | |||
|---|---|---|---|---|---|
AQP1 | Vessels | Intensity = 3 | 13 (86.7%) | 10 (66.7%) | NS |
Extension = 3 | 14 (93.3%) | 14 (93.3%) | NS | ||
Type 2 pneumocytes | Intensity = 3 | 4 (26.7%) | 5 (33.3%) | NS | |
Extension = 3 | 1 (6.7%) | 8 (53.3%) | 0.016 | ||
Basal cells | Intensity = 3 | 0 (0%) | 0 (0%) | NS | |
Extension = 3 | 0 (0%) | 0 (0%) | NS | ||
AQP5 | Vessels | Intensity = 3 | 7 (46.7%) | 5 (33.3%) | 0.094 |
Extension = 3 | 3 (20%) | 2 (13.3%) | NS | ||
Type 2 pneumocytes | Intensity = 3 | 1 (6.7%) | 0 (0%) | NS | |
Extension = 3 | 2 (13.3%) | 2 (13.3%) | NS | ||
Basal cells | Intensity = 3 | 5 (33.3%) | 3 (20%) | NS | |
Extension = 3 | 5 (33.3%) | 8 (53.3%) | NS |